SERUM INTERLEUKIN-2 LEVELS IN A PATIENT WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS - RELATIONSHIP TO CLINICAL COURSE AND CYCLOSPORINE A THERAPY

被引：17

作者：

JORDAN, SC

QUERFELD, U

TOYODA, M

PREHN, J

机构：

[1] Pediatric Renal Immunology Laboratory, Ahmanson, Pediatric Center, Cedars-Sinai Medical Center, Los Angeles, 90048, California

来源：

PEDIATRIC NEPHROLOGY | 1990年 / 4卷 / 02期

关键词：

Cyclosporin A; Focal segmental glomerulosclerosis; Interleukin-2;

D O I：

10.1007/BF00858831

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

We describe a patient with steroid-resistant focal segmental glomerulosclerosis (FSGS) whose serum interleukin-2 (IL-2) levels were markedly elevated in association with disease activity. With cyclosporin A (CsA) treatment, the patient entered remission and serum IL-2 fell to undetectable levels. After cessation of CsA, the patient relapsed and the serum IL-2 levels were elevated again. Reinstitution of CsA therapy was followed by a partial remission and disappearance of detectable serum IL-2 levels. © 1990 IPNA.

引用

页码：166 / 168

页数：3

共 12 条

[1]

Meyrier A., Simon P., Perret G., Condamin M.C., Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A, Br Med J, 292, pp. 789-792, (1986)

[2]

Tejani A., Butt K., Trachtman H., Suthanthiran M., Rosenthal C., Khawar, Cyclosporin-induced remission of relapsing nephrotic syndrome in children, J Pediatr, 111, pp. 1056-1061, (1987)

[3]

Waldo R., Kohaut E., Therapy of focal segmental glomerulosclerosis with cyclosporin A, Pediatr Nephrol, 1, pp. 180-182, (1987)

[4]

Niaudet P., Habib R., Tete M-J, Hinglas N., Broyer M., Cyclosporin in the treatment of idiopathic nephrotic syndrome in children, Pediatr Nephrol, 1, pp. 566-573, (1987)

[5]

Schnaper H.W., Aunne T.M., Identification of the lymphokine soluble immune response suppressor in urine of nephrotic children, J Clin Invest, 76, pp. 341-349, (1985)

[6]

Tejani A., Khalid B., Trachtman H., Suthanthiran M., Rosenthal C., Khawm M., Cyclosporin A induced remission of relapsing nephrotic syndrome in children, Kidney Int, 33, pp. 729-734, (1988)

[7]

Barnett H.L., Schoeneman M., Bernstein J., Edelmann C.M., Pediatric kidney diseases, pp. 695-711, (1978)

[8]

Wiesinger D., Borel J.F., Studies on the mechanisms of action of cyclosporin A, Br J Pharmacol, 66, pp. 66-67, (1979)

[9]

Bunjes D., Hardt C., Solbach W., Studies on the mechanism of action of cyclosporin A in the murine and human T-cell response in vitro, Cyclosporin A, pp. 261-280, (1982)

[10]

Abb J., Abb H., Effect of cyclosporine on human leukocyte interferon production: selective inhibition of IFN-gamma synthesis, Transplant Proc, 15, pp. 2380-2383, (1983)

← 1 2 →